Skip to main content
Ananda Pharma Plc logo

Ananda Pharma Plc — Investor Relations & Filings

Ticker · ANAN ISIN · GB00BDQPXQ60 LEI · 894500DFM8VOC5FW4X47 Aquis Stock Exchange Manufacturing
Filings indexed 196 across all filing types
Latest filing 2020-04-07 Regulatory Filings
Country GB United Kingdom
Listing Aquis Stock Exchange ANAN

About Ananda Pharma Plc

https://www.anandapharma.co.uk/

Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.

Recent filings

Filing Released Lang Actions
Ananda Developments Plc - Update on Medical Cannabis Growing Licence
Regulatory Filings Classification · 95% confidence The document is a press release issued by Ananda Developments Plc regarding the status of a medical cannabis growing license application with the Home Office and the MHRA. It provides operational updates on business activities and regulatory interactions. Since it does not fit into specific categories like financial reports, board changes, or dividend announcements, and is a standard corporate update released via a Regulatory Information Service, it falls under the general regulatory filing category.
2020-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.